PITOLISANT IS A “PORTFOLIO IN A PRODUCT” OPPORTUNITY!

Harmony Biosciences, Inc. (NASDAQ: HRMY) is a commercial-stage biopharmaceutical company developing novel therapeutics for rare and orphan diseases, focusing on central nervous system disorders. ...read more